Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02195531 · ClinicalTrials.gov registry record · NA

CPAP (Continuous Positive Airway Pressure) Study Educational Materials and Usage Feedback to Promote CPAP Adherence

A NA study, sponsored by Philips Respironics.

Completed
Registry status
NA
Development phase
169
Enrollment target

NCT02195531: Completed NA study, sponsored by Philips Respironics.

NCT02195531 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 169 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02195531, a NA study, has completed, sponsored by Philips Respironics.

COMPLETED
Registry status
NA
Development phase
169 participants
Enrollment target

Study Summary

The study hypothesis: in groups receiving tailored education and feedback in a style that matches their psychological profile, will show a higher CPAP adherence rates than groups receiving mismatched tailored education / feedback, and groups that receive no tailored education and feedback (standard of care).

Primary Outcome

Average usage hours per night

Interventions

  • BEHAVIORAL Education and feedback

Trial Details

FieldValue
Enrollment Target 169 participants
Start Date 2014-01
Est. Completion 2015-05
Phase NA
Philips Respironics

35 total trials

What the finished NCT02195531 record still lists

NCT02195531 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which Education and feedback is the first listed.

NCT02195531 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02195531 about?

NCT02195531 is a clinical study titled "CPAP (Continuous Positive Airway Pressure) Study Educational Materials and Usage Feedback to Promote CPAP Adherence". The study hypothesis: in groups receiving tailored education and feedback in a style that matches their psychological profile, will show a higher CPAP adherence rates than groups receiving mismatched tailored education / feedback, and groups that receive no tailored education and feedback (standard ...

What is the current status of trial NCT02195531?

This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2014-01. Estimated completion is 2015-05.

What interventions are being tested in trial NCT02195531?

The interventions under investigation include: Education and feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT02195531?

This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02195531's enrollment target sits among peer trials

169 619th of 2000 higher than 1,382 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06191484 · 169 participants · NA

    Risk and Resilience to Suicide Following Late-Life Spousal Bereavement

  • NCT02016430 · 170 participants · NA

    Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)

  • NCT02621021 · 170 participants · Phase 2

    A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab

  • NCT04094701 · 170 participants · NA

    Hip Arthroscopy Postoperative Opioid Demands

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02195531, the US trial registry maintained by the National Library of Medicine. NCT02195531 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.